Contingency management for Opioid Use Disorder

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Cooper University Hospital, Camden, NJOpioid Use DisorderContingency management - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is designed to increase the effectiveness of an existing emergency department "bridge" program for opioid use disorder by adding contingency management to the program.

Eligible Conditions
  • Opioid Use Disorder

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Prize-Based Contingency Management
1
Remote Contingency Management (CM) for nicotine abstinence
1
Buprenorphine: Dosing Group

Study Objectives

4 Primary · 4 Secondary · Reporting Duration: 3-months

1 week
Attendance at first scheduled clinic appointment
3-months
Delay discounting as a correlate of opioid-free urine test results and buprenorphine-positive results
Neurological Soft Signs correlate with treatment success
Opioid demand as a correlate of opioid-free urine test results and buprenorphine-positive results
Percentage of sessions where buprenorphine positive urine results was recorded
Percentage of sessions where opioid free urine results were recorded
Substance-free activities as a correlate of opioid-free urine test results and buprenorphine-positive results
Treatment acceptability

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
Prize-Based Contingency Management
1
Remote Contingency Management (CM) for nicotine abstinence
2
Buprenorphine: Dosing Group

Trial Design

2 Treatment Groups

Standard Care
1 of 2
Contingency Management
1 of 2

Active Control

Experimental Treatment

100 Total Participants · 2 Treatment Groups

Primary Treatment: Contingency management · No Placebo Group · N/A

Contingency Management
Behavioral
Experimental Group · 1 Intervention: Contingency management · Intervention Types: Behavioral
Standard CareNoIntervention Group · 1 Intervention: Standard Care · Intervention Types:
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Contingency management
2006
Completed Phase 4
~880

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 3-months

Who is running the clinical trial?

The Cooper Health SystemOTHER
67 Previous Clinical Trials
21,107 Total Patients Enrolled
Rowan UniversityLead Sponsor
21 Previous Clinical Trials
2,653 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
People who want to be in the Bridge program must be new enrollees, who have their first appointment at the Cooper Outreach Clinic within a week of enrollment.
You are at least 18 years of age.

Who else is applying?

What state do they live in?
Washington100.0%
How old are they?
18 - 65100.0%
What portion of applicants met pre-screening criteria?
Did not meet criteria100.0%
References

Frequently Asked Questions

Are there any vacancies for subjects to join this research experiment?

"Affirmative. The information found on clinicaltrials.gov indicates that this trial is recruiting participants as of now. This experiment was first made available to the public on January 27th 2020 and has been edited most recently on November 23rd 2021. It requires a total of 100 volunteers from one medical site for completion." - Anonymous Online Contributor

Unverified Answer

What is the overall enrollment for this clinical research project?

"Yes, according to clinicaltrials.gov, the trial is currently seeking participants with a post date of January 27th 2020 and an edit date of November 23rd 2021. 100 individuals will be enrolled across one site." - Anonymous Online Contributor

Unverified Answer

What are the main aims of this medical experiment?

"This 3-month trial will measure patient Attendance at first scheduled clinic appointment as its primary outcome. Secondary endpoints include an evaluation of Opioid demand correlated with drug test results for opioid abstinence and buprenorphine adherence, a drawing task to assess Neurological Soft Signs associated with successful treatment, and Substance-free activities linked to urine tests measuring opioid abstention and buprenorphine compliance." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top